World-first cancer drugs could work in larger group of patients

| March 19, 2015 | 0 Comments

( Institute of Cancer Research ) A pioneering class of drugs that target cancers with mutations in the BRCA breast cancer genes could also work against tumors with another type of genetic fault, a new study suggests. Scientists at The Institute of Cancer Research, London, found that errors in a gene called CLBC leave cancer cells vulnerable to PARP inhibitor drugs. Around 2 percent of all tumors …

Read the original post:
World-first cancer drugs could work in larger group of patients

Tags: , , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply